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Abstract
Regulation of glutamate transporters accompanies plasticity of some glutamatergic synapses. The
regulation of glutamate uptake at the Aplysia sensorimotor synapse during long-term facilitation
(LTF) was investigated. Previously, increases in levels of ApGT1 (Aplysia glutamate transporter
1) in synaptic membranes were found to be related to long-term increases in glutamate uptake. In
this study, we found that regulation of ApGT1 during LTF appears to occur post-translationally.
Serotonin (5-HT) a transmitter that induces LTF did not increase synthesis of ApGT1. A pool of
ApGT1 appears to exist in sensory neuron somata, which is transported to the terminals by axonal
transport. Blocking the rough endoplasmic reticulum (RER)- Golgi-trans-Golgi network (TGN)
pathway with Brefeldin A prevented the 5-HT-induced increase in ApGT1 terminals. Also, 5-HT
produced changes in post-translational modifications of ApGT1 as well as changes in the levels of
an ApGT1-coprecipitating protein. These results suggest that regulation of trafficking of ApGT1
from the vesicular trafficking system (RER-Golgi-TGN) in the sensory neuron somata to the
terminals by post-translational modifications and protein interactions appears to be the mechanism
underlying the increase in ApGT1, and thus, glutamate uptake during memory formation.
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Introduction
Clearance of glutamate from the synaptic cleft occurs through diffusion and uptake of
glutamate by high-affinity transporters. Consequently, glutamate transporters affect
numerous aspects of synaptic transmission (reviewed in Danbolt, 2001; Huang and Bergles,
2004). Glutamate transporters are regulated by many factors at the transcriptional,
translational and post-translational levels, but regulation of their trafficking to the membrane
by phosphorylation and/or protein interaction also appears to be important (for review see
Gegelashvili and Schousboe, 1997; Danbolt, 2001; Levenson, 2002b; Robinson, 2002, 2003;
Gonzalez and Robinson, 2004a, 2004b).
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Previously, we demonstrated that plasticity of glutamate uptake accompanies changes in
synaptic efficacy and learning in Aplysia and the rat hippocampus (Levenson et al., 2000b;
Levenson et al., 2002a; Pita-Almenar et al., 2006). In Aplysia, an increase in glutamate
uptake in pleural-pedal synaptosomes parallels the occurrence of long-term facilitation
(LTF) of the synapses between sensory neurons in pleural ganglia and their associated motor
neurons in pedal ganglia, and long-term sensitization (LTS) of the tail-siphon withdrawal
reflex (Levenson et al., 2000b). Regulation of glutamate uptake appears to be one of the
expression mechanisms of LTS/LTF because both LTS/LTF and glutamate uptake are, to a
large extent, co-regulated through the same signaling pathways (Khabour et al., 2004).
Moreover, an increase in the high-affinity Aplysia glutamate transporter 1 (ApGT1) in
pleural-pedal synaptic membranes appears to be responsible for the long-term increase in
glutamate uptake associated with LTS (Collado et al., 2007). The long-term increase in
ApGT1 protein in synaptosomes did not appear to be dependent upon an increase in ApGT1
gene expression or a translocation of ApGT1 from a synaptic vesicle pool to the plasma
membrane (Collado et al., 2007).
In the present study, ApGT1 was located in sensory neuron cell bodies and varicosities and
ApGT1 was synthesized in the cell body of sensory neurons and transported to the terminals
by axonal transport. However, the increase in synaptosomal ApGT1 was not due to somatic
or local newly synthesized ApGT1 but most likely due to transport of already synthesized
ApGT1 to the terminals. Thus, we proposed that the transport of ApGT1 from a pre-existing
pool in the somata of sensory neurons to the terminals was regulated by 5-HT. In support of
this hypothesis, 5-HT produced a substantial decrease in the amount of labeled ApGT1 in
the pleural ganglia. Moreover, blockade of the vesicular trafficking system [rough
endoplasmic reticulum (RER)- Golgi-trans-Golgi network (TGN)] with Brefeldin A
prevented the 5-HT-induced increase of ApGT1 in synaptosomes. Importantly, the pattern of
post-translational modifications of ApGT1 was altered by 5-HT, indicating that
phosphorylation and/or changes in glycosylation of ApGT1 occurred during LTF.
Interestingly, 5-HT produced an increase in a newly synthesized protein named ACOP
(ApGT1 co-precipitating protein), suggesting that ACOP may be involved in regulating
ApGT1 during LTF. Our findings suggest that regulation of transport of proteins from the
vesicular trafficking system to terminals by post-transcriptional modifications and/or
protein-protein interactions is an important mechanism of regulation of membrane proteins
involved in the expression of LTS/LTF.
Material and Methods
Pleural-pedal ganglia (8-10/group) were removed from Aplysia and incubated in isotonic
L-15 (Atlanta Biologicals) and buffered filtered sea water (1:1) for 3 h prior to drug
treatments in this media. After treatments, ganglia were maintained in culture media [L-15
and hemolymph (1:1)] at 15°C.
Cultures of Aplysia sensory neurons were prepared as previously described (Schacher and
Proshansky, 1983; Chin et al., 1999; Levenson et al., 2000b) and incubated for 5 to 6 days
in equal parts isotonic L-15 and hemolymph. Cultures with a minimum of 20 cells/plate
were used in the experiments. Cultures were treated with drugs in a 1:1 mixture of isotonic
L15 and BFSW. When isolated sensory neuron processes were used, the cell bodies of
sensory neurons were removed by cutting the axon at a distance of about 50-70 μm from the
cell body using a glass microelectrode and aspirating them with the microelectrode. Such
isolated processes remain viable in culture for over 48 h (Schacher and Wu, 2002; Liu et al.,
2003).
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To obtain large membranes, tissues were homogenized in grinding buffer (GB; 150 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 20 mM Tris, pH 7.5 and protease inhibitor cocktail) and
centrifuged (16,000 g, 5 min) at 4 °C to pellet large membranes. The resulting pellet was
resuspended in 1% SDS with 10 mM Tris (pH 7.5) or lysis buffer (see below) to give “large
membranes”. Synaptosomes were immediately prepared after removal of ganglia as
previously described (Chin et al., 1989; Chin et al., 1990; Levenson et al., 2000b).
Prior to 35S incorporation, tissues were incubated in “cold” media (L-15 without methionine
and cysteine, Atlanta Biologicals) and BFSW (1:1) for 3 h. To label newly synthesized
proteins, tissues were then incubated for 12 h in 3-5 ml of culture media with 35S
methionine and 35S cysteine (0.5 mCi/ml; Perkin Elmer) at 15 °C. During chase periods,
ganglia were incubated in “cold” media. After labeling and chase periods, synaptosomes or
membrane proteins were prepared and ApGT1 was purified by Immunoprecipitation (IP).
To obtain ApGT1, membrane protein fractions were lysed in an IP lysis buffer (1 mM
Na3VO4, 10 mM Na2HPO4, 1% Triton X-100, 20 mM NaF, 50 mM NaCl, 20 mM Tris plus
protease inhibitor cocktail, pH 7.6). Cell lysate protein (15 - 25 μg) was preadsorbed for 1 h
with Protein G beads (Sigma) and subsequently incubated at 4°C overnight with anti-
ApGT1 antibody. Antigen-antibody complex was bound by Protein G- sepharose at 4°C for
3h. Precipitated proteins were dissociated by incubation with sample loading buffer (3%
glycerol, 9% SDS, 15% 2-mercaptoethanol, 0.2% bromophenol blue, 375 mM Tris, pH =
6.8) and boiling for 10 min. Protein samples were resolved via SDS-PAGE, transferred, and
blotted using the ApGT1 antibody. After Western blotting, the membranes were exposed to
X-ray film to detect only 35S labeled protein. Blotting of the membrane did not interfere
with subsequent autoradiography.
Two-dimensional gel electrophoresis was performed (O’Farrell, 1975) by Kendrick Labs,
Inc. (Madison, WI). Isoelectric focusing was carried out using 1% pH 3.5-10 and 1% pH
2.5-5 ampholines or 2% pH 3.5-10 ampholines (GE Healthcare, Piscataway, NJ) for 20,000
volt-h. SDS slab gel electrophoresis (10% acrylamide) was carried out for about 5 h at 25
mA/gel. The gel was then transferred onto PVDF membranes overnight at 225 mA and
approximately 100 volts/ two gels and blotted for ApGT1.
Glutamate Uptake, Western blots, immunostaining procedures and statistical analysis are
described in the Supporting information.
Results
5-HT treatments of isolated pleural-pedal ganglia increased ApGT1 in synaptosomes
To develop an in vitro system to study regulation of ApGT1, we tested whether ApGT1 was
increased in synaptosomes from pedal ganglia 24 h after exposure of isolated pleural-pedal
ganglia to 5-HT (2 h, 50 μM), a treatment that mimics the effects of behavioral training and
leads to the induction of LTF (Emptage and Carew, 1993; Zhang et al., 1997). 5-HT
increased the levels of ApGT1 in pedal synaptosomes 24 h after treatment (61 ± 23%, n =
11, one-tailed t-test, t = 2.706, p = 0.01; Fig. S1). The result of this experiment further
suggests that an increase in ApGT1 is responsible for the increase in glutamate uptake
(Levenson et al., 2000b; Khabour et al., 2004).
ApGT1 localizes in pleural sensory neuron cell bodies and varicosities
To study regulation of ApGT1, we determined the locus of ApGT1 expression and
synthesis, its half-life and how ApGT1 was transported to synaptic terminals. ApGT1 was
localized in pleural-pedal ganglia by immunofluorescence using an anti-ApGT1 antibody
(Collado et al., 2007). DAPI staining identified nuclei. High levels of ApGT1
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immunoreactivity were found surrounding the nucleus of small sensory neurons in the
pleural ganglia (SNs, see cells inside circle, Fig. 1a and cells labeled as SN, Fig. 1c) and in
fibers coming from the sensory neuron cluster (arrowheads, Fig. 1a and c). ApGT1 staining
in sensory neuron cell bodies appeared to be in the plasma membrane and in association
with internal membranes, presumably RER and/or Golgi, but not in the nucleus. In addition,
high levels of ApGT1 immunoreactivity was associated with glial cells (small nuclei, see
white arrows) surrounding neurons as well as with processes (arrowheads) and/or glia
(arrows) in connectives and neuropil (Fig. 1a and c). This pattern of staining correlates with
the in situ hybridization pattern of ApGT1 mRNA (Levenson et al., 2000a). The
immunostaining for ApGT1 was specific because cells from the sheath surrounding the
ganglion showed no staining (see yellow arrows, Fig. 1a and b) as expected from in situ
hybridization studies (Levenson et al., 2000a). Moreover, tissue stained under the same
conditions but lacking primary antibody did not show staining (Fig. 1e). Thus, in pleural
ganglia, ApGT1 appears to be found in sensory neuron cell bodies and processes as well as
in glial cells.
In pedal ganglia, some ApGT1 staining was found surrounding pedal neurons (PN, Fig. 1b),
but no staining was observed surrounding the nucleus of these large cells suggesting that
ApGT1 was not in the soma of these neurons (see N1, Fig. 1d). The examination of stained
pedal ganglia at high magnification (60x) revealed that ApGT1 was found associated with
small nuclei (glial cells, see white arrows) surrounding the large neuronal cell bodies and
with glial indentations into the neuronal cell bodies (see red arrows pointing to glial
indentations into cell N2), in agreement with previous morphological studies (Coggeshall,
1967). High intensity staining for ApGT1 was also found associated with glial cells (white
arrows) in connectives and the periphery of the neuropil (data not shown). Staining inside
the neuropil of pedal ganglia was associated with glia but some fiber-like staining was also
observed (bottom left corner Fig. 1b, data not shown). Thus, in pedal ganglia,
immunoreactivity for ApGT1 was mostly associated with glial cells and presumably
processes of sensory and/or other neurons in the neuropil.
To compare levels of ApGT1 between different compartments in pleural-pedal ganglia,
levels of ApGT1 were measured by western blot in sensory neuron clusters (where sensory
neuron cell bodies are located), pedal neuropil (where processes of sensory neuron are
located) and the remainder of pleural or pedal tissue. Levels of ApGT1 were much higher in
tissues from pleural ganglia than in tissues from pedal ganglia (Fig. 1f). Moreover, ApGT1
was much more concentrated in sensory neuron clusters than in the pedal or pedal neuropil,
demonstrating that there are high levels of ApGT1 in sensory neuron cell bodies consistent
with a large pool of ApGT1 available in somas but not processes of sensory neurons.
The subcellular distribution of ApGT1 was studied in isolated cultured sensory cells. Results
from 30 cultures (a total of 80 pleural sensory cells) showed that ApGT1 was in the sensory
neuron cell body as well as in varicosities (Fig. 2a, arrowheads). ApGT1 immunoreactivity
was not detected in the nucleus of sensory neurons (SN, Fig. 2b1). Immunostaining for
ApGT1 was brighter in the sensory neuron cell body than in the processes or varicosities
(arrowheads), suggesting again that a pool of ApGT1 exists in the sensory neuron cell body
available for transport. Cultures that were not incubated with primary antibody and did not
show any staining (n = 7 cultures). Moreover, the immunostaining for ApGT1 was competed
out by preadsorption with the antigen peptide (n = 5 cultures, Fig. 2c). These results from
cultured sensory neurons support our data on pleural-pedal ganglia suggesting that ApGT1
is found in cell bodies and terminals of pleural sensory neurons.
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ApGT1 was synthesized by pleural sensory neurons and transported to terminals in pedal
ganglia
To determine the locus of ApGT1 synthesis, isolated pleural ganglia and isolated pedal
ganglia were incubated with radioactive methionine and cysteine for 12 h. Since pleural
ganglia yield very little protein, the entire sample was used to start immunoprecipitations
(IPs). The amount of newly synthesized ApGT1 relative to total ApGT1 was 8-fold greater
in pleural ganglia than in pedal ganglia (Fig. 3a). Also, the amount of newly synthesized
ApGT1 relative to total ApGT1 was 4-fold greater in isolated pleural sensory neuron
clusters (SN clusters) than in the remaining pleural ganglia tissue after removal of sensory
clusters (Re pleural) (Fig. 3b). These results suggest that the rate of synthesis of ApGT1 is
lower in glia than in sensory neurons. Thus, newly synthesized ApGT1 observed in sensory
clusters was most likely due to ApGT1 synthesized by pleural sensory neurons.
What is the source of ApGT1 in synaptosomes (terminals) from pedal ganglia? We
hypothesized that ApGT1 was synthesized in somata of sensory neurons in the pleural
ganglia and transported to terminals in the pedal ganglia. To test this hypothesis, labeled
ApGT1 was measured in pedal synaptosomes (a preparation enriched in neuronal terminals
and almost devoid of glial material, Levenson et al., 2000b) using a pulse-chase protocol.
Isolated pleural-pedal ganglia were incubated with 35S-methionine and cysteine for 12 h, at
which point the protein synthesis inhibitor anisomycin (20 μM) was added to the bath. Some
ganglia were lysed immediately after the 12 h incubation in label (0 h), and the rest after a 6
or 12 h chase period in the presence of anisomycin (Fig. 4a). Levels of newly synthesized
ApGT1 were normalized to levels of total ApGT1 in synaptosomes, which remained
unchanged in all groups compared to the 0 h time point (two-tailed t-test, all groups p >
0.05). Newly synthesized ApGT1 was detected in synaptosomes after 12 h of incubation
(Fig. 4a). The newly synthesized ApGT1 might be due to ApGT1 synthesized in the soma
and transported to the terminals or synthesized locally at the terminals. The lag period of 12
h in theory allows ApGT1 to be synthesized in the pleural ganglia and transported to the
terminals of the pedal ganglia (Goldberg et al., 1981). Labeled ApGT1 in synaptosomes
increased after chase periods of 6 and 12 h in the presence of anisomycin. The level of
labeled ApGT1 was significantly increased by 3.5-fold after the 12 h chase period (One
sample t-test, t = 3.216, df = 7, p < 0.02; Fig. 4a and b). Because protein synthesis was
inhibited during the chase period, the increase in ApGT1 was most likely due to transport of
previously synthesized ApGT1 to the terminals. This result also indicates that ApGT1 is not
being degraded; therefore, the half-life of ApGT1 at the terminals may be longer than 12 h.
A long half-life of ApGT1 is also supported by experiments showing no decrease in
glutamate uptake after treatment of pleural-pedal ganglia with anisomycin for 24 h and 72 h
(Khabour and Eskin, unpublished observations).
In Aplysia, the anterograde transport of vesicles containing glycoproteins occurs by fast
axonal transport through microtubules at a rate of approximately 100-170 mm/day
(Goldberg et al., 1981). Does the increase in ApGT1 in synaptosomes after the chase period
result from microtubule-dependent transport? To examine this issue, colchicine (10 mM), an
inhibitor of microtubule polymerization in Aplysia (Goldman et al., 1976), was added after
12 h of incubation in label and labeled ApGT1 was measured in pedal synaptosomes 12 h
later. The addition of colchicine completely blocked the increase in labeled ApGT1 seen
after a 12 h chase period (One-tailed t-test with Welch’s correction, t = 2.785, df = 8, p <
0.01; Fig. 4a and c). This result indicates that the increase in ApGT1 in pedal synaptosomes
after the chase period is due to microtubule-dependent axonal transport.
To further test whether ApGT1 synthesized in the pleural ganglia is the source of the
ApGT1 transported to pedal terminals, pleural-pedal ganglia were incubated in label for 12
h, and then pleural ganglia were surgically removed from pedal ganglia and isolated pedal
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ganglia were further incubated in label for 12 h in the presence of anisomycin. Removing
pleural ganglia before the chase period significantly reduced the increase of ApGT1 in pedal
synaptosomes observed 12 h after the chase period in attached pleural-pedal ganglia (Fig.
4c; One-tailed t-test with Welch’s correction, t = 2.046, df = 8, p < 0.04). A small amount of
transport to terminals appeared to occur during the chase period even after pleural ganglia
were removed (Fig. 4c). However, the magnitude of the increase of labeled ApGT1 in
isolated pedal ganglia was reduced by 170 % when pleural ganglia were removed from
pedal ganglia during the chase period. Some percentage of the increase seen within the pedal
ganglia after removal of the pleural ganglia was likely due to labeled ApGT1 already in the
pleural-pedal connectives that then continued transport to the terminals during the chase
period. In summary, ApGT1 appears to be synthesized in the cell body of pleural sensory
neurons and transported to the terminals in pedal ganglia by axonal transport. Also, ApGT1
appears to have a long half-life in the terminals.
The increase of ApGT1 in synaptic terminals after 5-HT was not due to an increase in
translation of ApGT1
Inhibition of protein synthesis during induction of the long-term increase in glutamate
uptake blocked the increase in glutamate uptake (Levenson et al., 2000b; Collado et al.,
2007). However, the requirement for protein synthesis for the increase in glutamate uptake
does not necessarily reflect an increase in the translation of the transporter, i.e., expression,
but rather may be part of the induction mechanisms underlying the increase in glutamate
uptake. We investigated whether 5-HT increases ApGT1 translation by measuring labeled
ApGT1 in pedal synaptosomes after 5-HT treatment of isolated pleural-pedal ganglia. This
experiment was designed (Fig. 5a) based on our previous results indicating that protein
synthesis is not required for the 24 h increase in glutamate uptake by 7.5 h after the
beginning of 5-HT treatment (Collado et al., 2007) and that at least 12 h are needed for
newly synthesized protein to accumulate in the terminals (Fig. 4). In this experiment,
immunoprecipitation procedures were begun with the same amount of protein in all groups
(Fig. 5b).
If the increase in ApGT1 was due to an increase in the synthesis of ApGT1 either in the
soma or terminals, then 5-HT treatments should increase the amount of label incorporation
into ApGT1 in pedal synaptosomes. No significant change in labeled, newly synthesized
ApGT1 was observed in pedal synaptosomes 20 h after 5-HT treatment (-16 ± 15 %, n = 4;
one-tailed t-test, t = 1.072, p = 0.18; Fig. 5b and c). However, in these same samples, total
ApGT1 was significantly increased in pedal synaptosomes both before IP (65 ± 29 %, n = 4,
one-tailed t-test, t = 2.270, p < 0.05) and after IP (53 ± 18 %, n = 6, one-tailed t-test, t =
4.541, p < 0.004; Fig. 5b and c). Thus, the 5-HT-induced increase in ApGT1 in
synaptosomes does not appear to be due to an increase in synthesis of ApGT1 in terminals
or somata but rather to more ApGT1 transported from a pre-existing pool in the soma of
sensory neurons to their terminals. Alternatively, the rate of endocytosis or degradation of
ApGT1 could be down regulated by 5-HT. However, since the half-life of ApGT1 appears
to be long (Fig. 4 and Khabour and Eskin, unpublished observations), it is more likely that
trafficking of ApGT1 rather than turnover of ApGT1 in the terminals is regulated during
induction of LTF.
It is possible that a change in synthesis of ApGT1 could be detected in the pleural ganglia
but not in pedal ganglia. Therefore, levels of labeled, newly synthesized ApGT1 were
measured in total membranes of pleural ganglia using the same experimental design (Fig.
5a). A significant decrease in labeled, newly synthesized ApGT1 was observed in pleural
ganglia treated with 5-HT compared with non-treated ganglia (-46 ± 9 %, n = 4, two tailed t-
test, p < 0.02, Fig. 5d). This result suggests that synthesis of ApGT1 was not increased by 5-
HT but the pool of labeled ApGT1 in the pleural ganglia appears to be reduced. The
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decrease in labeled ApGT1 in the pleural was observed 20 h after 5-HT treatment, so it is
possible that the newly synthesized labeled ApGT1 was transported to the terminals
subsequent to the transport of ApGT1 from an unlabeled pool. The transport of newly
synthesized ApGT1 probably occurred later than unlabeled ApGT1, which may already be
in the TGN or transport vesicles. This would explain why labeled ApGT1 did not increase in
the pedal synaptosomes by 20 h. These results strongly suggest that the pool from which
ApGT1 is transported resides in the soma of sensory neurons.
Interestingly, a 35S-labeled 60-65 KDa protein that runs just below ApGT1 and was not
recognized by the ApGT1 antibody was observed in autoradiographs from IPs in all the
fractions studied (membranes from pleural and pedal ganglia, sensory neuron clusters and
synaptosomes, e.g., see Figs. 3a and 4a). This protein that consistently, and specifically, co-
immunoprecipitated with ApGT1 was named ACOP (ApGT1 co-precipitating protein). 5-
HT significantly increased the level of 35S-labeled co-immunoprecipitated ACOP in
synaptosomes 20 h after treatment (37 ± 11 %, n = 6, two-tailed t-test, t = 3.370, p < 0.02;
Fig. S2). These results suggest that ACOP might be involved in the trafficking or regulation
of ApGT1. Although identification of ACOP was attempted, ACOP’s identity remains
unknown.
The pleural ganglia as well as sensory neuron cell bodies are required for the
transcription-dependent long-term increase in glutamate uptake
Previous experiments suggested that a pool of ApGT1 in sensory neuron cell bodies might
be the source of the increase in ApGT1 by 5-HT. To determine whether sensory neuron cell
bodies were required for the increase in glutamate uptake, isolated pedal ganglia were
treated with 5-HT. Treatment of isolated pedal ganglia with 5-HT (50 μM, 1.5 h) led to an
increase in glutamate uptake 24 h later (27 ± 7%, n = 13, p < 0.05, Fig. 6a). The amplitude
of the increase in glutamate uptake was lower than that produced in the presence of sensory
neuron cell bodies (45 ± 8% versus 27 ± 7% respectively, Fig. 6a). Moreover, treatment of
isolated pedal ganglia with the transcription inhibitor DRB (100 μM, added 30 min prior to
5-HT treatment and throughout the experiment) did not affect the increase in glutamate
uptake produced by 5-HT on isolated pedal ganglia. (31 ± 8%, n = 9, p > 0.05, Fig. 6a) The
basal levels of glutamate uptake (3 ± 3%, n = 6, p > 0.05, Fig. 6a) were also not affected by
DRB. In contrast, the increase in glutamate uptake produced in vivo by electrical stimulation
and in vitro by exposing isolated pedal-pleural ganglia or cultured sensory neurons to 5-HT
was completely inhibited by DRB (Levenson et al., 2000b; Khabour and Eskin,
unpublished). These results suggest that cell bodies of sensory neurons are required for
obtaining the transcription-dependent full increase in glutamate uptake measured in pedal
synaptosomes.
We also investigated the role of sensory neuron cell bodies in eliciting changes in glutamate
uptake in sensory neurons in culture. Sensory neuron cell bodies were removed and
processes were then exposed to 5-HT (50 μM, 1.5 h) 2-3 h later. Aplysia neuronal processes
in culture have been shown to remain healthy and functional at least 48 h after the removal
of cell bodies (Schacher and Wu, 2002; Liu et al., 2003). Removal of the sensory neuron
cell bodies from cultured sensory neurons decreased glutamate uptake by approximately
50% because glutamate transporters are also localized in the plasma membrane of cell
bodies (data not shown). 5-HT did not induce significant changes in glutamate uptake in
neuronal processes measured 24 h after the 5-HT treatment (13 ± 11%, n = 10, p > 0.05, Fig.
6b). In contrast, treatment of intact cultured sensory neurons with 5-HT produced a long-
term increase in glutamate uptake measured 24 h later (72 ± 14%, n = 8, p < 0.01, Fig. 6b).
Thus, the presence of sensory neuron cell bodies is required for the production of the long-
term increase in glutamate uptake in cultured sensory neurons. This result also indicates that
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the pool of transporters required for the change in glutamate uptake resides in intracellular
stores in the soma of sensory neurons.
The long-term increase of ApGT1 in pedal synaptosomes appeared to require transport
through the RER-Golgi-TGN network
Lack of transcriptional or translational regulation together with other results led us to
hypothesize that regulation of the transport of ApGT1 from the vesicular trafficking system
(RER-Golgi-TGN) to terminals by 5-HT is responsible for the long-term increase of ApGT1
in synaptosomes. To test this, isolated pleural-pedal ganglia were exposed to 5-HT (1.5 h, 50
μM), and then to Brefeldin A (18 μM) for 22.5 h. Brefeldin A, an inhibitor of COPI and
some clathrin-mediated endocytosis, blocked the long-term increase in glutamate uptake
(Levenson et al., 2000b). Brefeldin A applied alone for 22.5 h did not affect the levels of
ApGT1 in pedal synaptosomes (7.1 ± 6.8 %; n = 7; one sample t-test, t = 1.041, p = 0.34;
Fig. 7), further supporting that ApGT1 has a long half-life at the terminals. As previously
shown, levels of ApGT1 were increased in pedal synaptosomes when isolated pleural-pedal
ganglia were treated with 5-HT (39.4 ± 2.4 %; n = 4; one sample t-test, t = 16.18, p =
0.0005; Fig. 7). Brefeldin A added to pleural-pedal ganglia after 5-HT treatment blocked the
long-term increase in ApGT1 (14.3 ± 5.2 %; n = 5; One-way ANOVA followed by Tukey’s
post hoc test: F = 6.887, df = 15, p = 0.009, Brefeldin A vs 5-HT: p < 0.01, Brefeldin A vs
5-HT + Brefeldin A: p > 0.05, 5-HT vs 5-HT+ Brefeldin A: p < 0.05; Fig. 7). Therefore,
transport of ApGT1 through RER-Golgi-TGN appears to be required for the long-term
increase in ApGT1 in synaptic terminals. Brefeldin also disrupts the cycling of proteins
through the endosomal system but it seems unlikely that ApGT1 is trafficked through this
system.
Most ApGT1 in the pleural ganglia appears to be mature since ApGT1 was EndoH
insensitive while PGNase F reduced the molecular weight of ApGT1 from ∼ 70 KDa to ∼60
KDa in the pleural demonstrating that ApGT1 is indeed a glycoprotein (Collado, MS and
Eskin, A, unpublished results). This difference in molecular weight is consistent with the
five N-linked oligosaccharide sites in ApGT1 containing complex oligosaccharides. This
result suggests that the ApGT1 pool in sensory neuron cell bodies might be located past the
RER, probably in the trans-Golgi and/or transport vesicles as observed for other amino acid
transporters (Hatanaka et al., 2006).
5-HT produced post-translational changes of ApGT1
Several consensus glycosylation and phosphorylation sites are present in the predicted
protein sequence of ApGT1 (Collado et al., 2007). Therefore, if exit of ApGT1 from the
RER-Golgi-TGN system is regulated by 5-HT, then a change in the phosphorylation pattern
and/or a change in ApGT1 maturation (indicated by differential glycosylation) should be
observed (Lodish et al., 2008). To test whether ApGT1 was regulated post-translationally by
5-HT, shifting of ApGT1 on high-resolution two-dimensional polyacrylamide gels (2D gels)
blotted with ApGT1 was studied.
ApGT1 exhibited extreme charge heterogeneity, a pattern very characteristic of
glycoproteins that can result from phosphorylation, glycosylation and/or other post-
translational modifications (Dunbar, 1987). The predicted molecular weight of ApGT1
based upon its sequence is 62 kDa. However, ApGT1 exhibited a moderate molecular
weight heterogeneity ranging approximately from 70 kDa to 75 kDa (Fig. 8a) that could
result mainly from differential glycosylation and to a less extent, other types of post-
translational modifications like phosphorylation which can account only for around 100
Daltons per phospho-site.
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Isolated pleural-pedal ganglia were treated with 5-HT for 2 h and prepared for gel analysis
24 h later. Some charge isoforms of ApGT1 disappeared or decreased after 5-HT treatment
(spots # 8, 9, 10 and 11; Fig. 8a and b) and some new charge isoforms of ApGT1 appeared
or increased after 5-HT treatment (spots # 1, 2, 3, 4, 5, 6, 7; Fig. 8a and b). This experiment
was repeated 3 times with similar results. The changes observed were mainly due to changes
in charge while changes in molecular weight were not apparent. Overall, it appeared that
most charge isoforms of ApGT1 were shifted from basic to acidic isoforms by 5-HT (Fig.
8b). The approximately 0.1 pH differences between protein spots observed in the 2D gels
are indicative of phosphorylation isomers. Moreover, about 9 protein spots are visible on the
5-HT 2D gel, consistent with 9 consensus phosphorylation sites found in ApGT1. This post-
translational regulation produced by 5-HT suggests that transport of ApGT1 to the terminals
may be regulated by phosphorylation.
Discussion
We have extended the knowledge of the regulation of ApGT1 during LTF and found that the
increase in ApGT1 in synaptosomes is induced and expressed in isolated pleural-pedal
ganglia treated with 5-HT. Therefore, ApGT1 and glutamate uptake increase in
synaptosomes, but not in the cell/glial fraction, from isolated ganglia treated with 5-HT or
intact animals exposed to either electrical stimulation or 5-HT (Levenson et al., 2000b and
Collado et al., 2007). Therefore, the regulation of levels of ApGT1 at the synaptic
membrane appears to be the mechanism of expression of the long-term increase in glutamate
uptake.
Although the long-term increase in glutamate uptake is dependent on macromolecular
synthesis, neither transcription nor translation of ApGT1 is regulated during LTS/LTF
(Collado et al., 2007 and Fig. 5). How can the requirement of transcription and translation
for the increase in glutamate uptake (Levenson et al., 2000b) be explained in light of a lack
of a change in synthesis of ApGT1? One possibility is that the requirement for transcription
and translation is for the induction phase of the increase in glutamate uptake. Another
possibility is that the increase in glutamate uptake could be dependent on the transcription of
genes or translation of proteins other than ApGT1, which may be important for the
expression of the change in glutamate uptake. An example of such proteins could be
glutamate transporter interacting proteins (e.g., targeting proteins), which might regulate
ApGT1 transport to the terminals (for review see Gonzalez and Robinson, 2004b). 5-HT
induced an increase in newly synthesized levels of ACOP, a protein that co-
immunoprecipitates with ApGT1 (Fig. S2). Thus, an increase in the translation of ACOP
could be one source of the requirement for translation.
What is the cellular source of increased ApGT1 in synaptic membranes? In this study, we
showed that high levels of ApGT1 were found in sensory neuron cell bodies in the sensory
cluster (Fig. 1) as well as in cell bodies and varicosities of cultured sensory neurons (Fig. 2).
Because the somata of sensory neurons synthesize ApGT1 and the somata contain ApGT1,
pleural sensory neurons appear to be a source of glutamate transporters (Fig. 1-3 and
Collado et al., 2007). Moreover, ApGT1 is transported from pleural ganglia to pedal
terminals in a microtubule-dependent manner (Fig. 4). Although high levels of ApGT1 are
also found in glial cells in pleural-pedal ganglia, glia do not appear to be the source of the
additional ApGT1 since the change in levels of ApGT1 and glutamate uptake is specific to
the synaptosomal fraction (which is enriched in neuronal terminals and almost depleted of
glia) and not observed in the cell/glial fraction (Levenson et al., 2000b;Collado et al., 2007).
Importantly, increases in glutamate uptake produced by 5-HT occur in cultures of isolated
sensory neurons that contain few if any glial cells. Furthermore, glia do not appear to
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synthesize ApGT1 at high rates (Fig. 3). Labeled ApGT1 measured in our pulse-chase
experiments most likely corresponded mainly to ApGT1 synthesized in sensory neurons.
The 5-HT-induced increase in ApGT1 may be due to trafficking of ApGT1 from a reserve
pool in somata of sensory neurons to the terminals. First, the higher rate of synthesis and
higher levels of ApGT1 found in the somata of sensory neurons than in pedal ganglia,
neuropil, and processes of cultured sensory neurons (Figs. 1-3; Collado et al., 2007) suggest
that a reserve pool of ApGT1 exists in the somata rather than in the processes of sensory
neurons. Second, pleural ganglia (presumably sensory neuron cell bodies) appear to be the
main source of ApGT1 transported to the terminals (Fig. 4c). Third, the increase in the
levels of ApGT1 observed in synaptosomes of pedal ganglia was not due to translation of
ApGT1 (Fig. 5) or to translocation from a synaptic vesicle pool to the membrane (Collado et
al., 2007). Also, 5-HT produced a substantial decrease in the amount of labeled ApGT1 in
the pleural ganglia appearing to reduce the pool in the pleural (Fig. 5d). Finally, pleural
ganglia and cell bodies of isolated sensory neurons are required for the full, normally
transcription-dependent increase in glutamate uptake by 5-HT (Fig. 6). What is the source of
the non-transcription dependent increase in uptake observed in isolated pedal ganglia (Fig.
6a)? These glutamate transporters may come from a pool existing in the pedal ganglion that
can be activated upon removal of the pleural ganglia.
The reserve pool of ApGT1 may be located in the Golgi network in the somata of sensory
neurons. The addition of the inhibitor of RER-Golgi-TGN transport Brefeldin A to pleural-
pedal ganglia after the 5-HT treatment blocked the increase of ApGT1 in synaptosomes
observed 24 h after 5-HT (Fig. 7). Brefeldin A blocks RER to Golgi transport and leads to
morphological changes due to tubulation and mixing of the TGN and endosomal system. It
is unlikely that ApGT1 would be targeted to the endosomal pathway. Moreover, trafficking
to and from the plasma membrane appears to remain normal when Brefeldin is present.
(Lippincott-Schwartz et al., 1991;Klausner et al., 1992). It seems most likely that Brefeldin
A blocked the increase in ApGT1 by disruption somewhere in the RER-Golgi-TGN pathway
but disruption of downstream targets cannot be ruled out. Thus, blocking the increase in
ApGT1 by Brefeldin A indicates the involvement of RER-Golgi-TGN trafficking.
Alternatively, Brefeldin A could be blocking trafficking of proteins important for the
induction pathway of the increase in ApGT1 and glutamate uptake by 5-HT and thus,
blocking the increase of ApGT1 indirectly. The majority of ApGT1 in pleural ganglia
appears to be in a mature form (Endo-H insensitive), suggesting that the pool of ApGT1
might be located past the RER, presumably in the Golgi or TGN as has been observed for
other amino acid transporters (Hatanaka et al., 2006).
Under basal conditions, ApGT1 exists as a set of proteins with extensive heterogeneity of
charge and small heterogeneity of molecular weight. 5-HT treatment of ganglia changed the
pattern of ApGT1 proteins showing that 5-HT regulated the post-translational modifications
of ApGT1. The 0.1 pH differences in protein spots observed in 2D gels are consistent with
phosphorylation isomers. Furthermore, the number of protein spots in 2D gels is similar to
the number of phosphorylation consensus sites for PKA and PKC in the ApGT1 protein
sequence. 5-HT activates both PKC and PKA (reviewed in Kandel, 2001), but only PKA is
required for the long-term increase in glutamate uptake (Khabour et al., 2004). Thus, it is
probable that ApGT1 is phosphorylated, at least by PKA, during 5-HT treatment. Surface
expression of mammalian glutamate transporters EAAC1 and GLT1 is modulated by direct
phosphorylation of transporters (Casado et al., 1993; Huang et al., 2006). Also, because the
carbohydrates may have charged oligosaccharides, ApGT1 may also exhibit 5-HT-induced
changes in carbohydrates during maturation as ApGT1 moves through the Golgi.
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How could changes in post-translational modifications affect ApGT1 trafficking and surface
expression in synaptic terminals? One possibility is that post-translational changes of
ApGT1 might facilitate interaction of ApGT1 with glutamate transporter associated proteins,
leading to their traffic to the terminals as shown for mammalian glutamate transporters (for
review see Gonzalez and Robinson, 2004b, Ruggiero et al., 2008). In agreement with this
hypothesis, an increase in labeled co-immunoprecipitated ACOP was induced by 5-HT,
suggesting that the interaction between ACOP and ApGT1 might be regulated and important
for the increase in ApGT1 by 5-HT. ACOP does not appear to be transported via
microtubules to the terminals (see Fig. 4a), suggesting that ACOP might be a cytoplasmic
protein. At this point, the nature and source of ACOP remains an intriguing mystery.
Regulation of trafficking (transport to the membrane) is an important mechanism for
synaptic plasticity in mammals (for review see Malenka, 2003) and some evidence suggests
that regulation of trafficking is also an important mechanism for learning and memory in
Aplysia. The trafficking (both endocytosis and exocytosis) of an Aplysia tyrosine kinase
receptor-like receptor (ApTrkl) was shown to be regulated by 5-HT (Nagakura et al., 2006).
Additionally, endocytosis of a membrane protein, ApCAM, was increased by 5-HT as was
the synthesis of clathrin (Bailey et al., 1992; Hu et al., 1993). The trafficking and clustering
of AMPA receptors in motor neurons appears to be modulated by synapse formation and 5-
HT (Li et al., 2006). Importantly, kinesin, the motor protein involved in anterograde
transport, may be regulated by 5-HT (Puthanveettil and Kandel, 2006) and disruption of
axonal transport by nocodazole applied to isolated siphon nerves completely blocked LTF at
distal synapses (Guan and Clark, 2006), suggesting that transport of proteins may be
upregulated and is required during synaptic plasticity.
A constellation of changes are involved in the formation of long-term memories. Our studies
in Aplysia, have allowed us to examine one of those changes (glutamate uptake) and
compare it with other changes involved in LTS/LTF. LTS/LTF and the increase in glutamate
uptake appear to be co-regulated in that the same signaling pathways are involved from
training until induction of C/EBP (Kandel, 2001; Khabour et al., 2004; Collado et al., 2005).
Our studies suggest that regulation of trafficking of ApGT1 from the Golgi-TGN leading to
increased ApGT1 in terminal membranes might be the mechanism of expression of the long-
term increase in glutamate uptake. A long half-life of ApGT1 may account at least for the
24h - 48h change in glutamate uptake. Our current hypothesis is that the exit of ApGT1 from
the Golgi-TGN is regulated through phosphorylation of ApGT1 by some of the kinases
activated during induction of LTF/LTS, leading to increased interaction of ApGT1 with a
chaperone protein whose transcription and/or translation is upregulated during LTS/LTF.
The study of the regulatory mechanisms of ApGT1 will help shed light on the mechanisms
that link induction and expression of memory.
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Fig. 1. Localization of ApGT1 in pleural-pedal ganglia
a. Section from pleural ganglion (20X) showing the sensory neuron cluster. Sensory neurons
(SNs) are mostly within the circle on the left side of the image (see small nuclei stained with
DAPI). Other pleural neurons different than sensory neurons can be observed (larger nuclei
on the right side of the image). ApGT1 staining (green) is observed at high intensity around
sensory neurons and other neurons as well. The pleural-pedal connective (arrowheads) can
be visualized as fibers stained with ApGT1 antibody. Small nuclei corresponding to glial
cells (white arrows) in connectives as well as surrounding neurons are immunostained. In
contrast, small nuclei (yellow arrows) found in the sheath of the ganglion (surrounding the
ganglia) do not stain. b. Section of a pedal ganglion (20X) showing a few pedal neurons
(PN, large DAPI-stained nuclei) as well as a portion of the neuropil (bottom left corner).
Pedal neurons show no cytoplasmic staining for ApGT1 but ApGT1 staining surrounds
them, presumably associated with glial cells (white arrows, see small nuclei surrounding
neurons). Pedal neuropil also stained for ApGT1 (see bottom left corner), presumably
associated with glial cells and neuronal terminals. c. A portion of a section of the sensory
neuron cluster taken at a high magnification (60x) showing sensory neuron cell bodies (SN)
as well as their axons and processes (arrowheads point to an axon coming from cell with *).
ApGT1 immunostaining is associated with sensory neurons as well as glial cells (white
arrows, see smaller nuclei). d. Section of pedal ganglia at high magnification showing pedal
neurons (N1, N2). Section is cut through the middle of N1 (DAPI-stained nucleus) but
through the periphery of N2 (notice the lack of DAPI staining). ApGT1 staining is not
associated with those neurons (N1 cytoplasm is not stained with ApGT1) but rather ApGT1
antibody stained glial cells (white arrows) and indentations of glial processes into the
neuronal cell bodies (red arrows, see ApGT1-stained processes). Scale bars are 50 μm in a,b
and 10 μm in c, d. e. Section of pedal ganglia at low magnification stained without antibody
but with DAPI and secondary antibody anti-rabbit-IgG Alexa-488 only. f. Pleural tissues
contain much more ApGT1 per protein than pedal tissues. A western blot for ApGT1 shows
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the relative amounts of ApGT1 in sensory neuron clusters (SN cluster), the remaining
pleural (Re Pleural), the pedal neuropil (Pe neuropil) and the remaining pedal (Re Pedal).
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Fig. 2. ApGT1 immunostaining of cultured sensory neurons
a. A section showing a sensory neuron with its axon and collaterals stained for ApGT1 and
DAPI. ApGT1 staining can be observed in the sensory neuron (SN) cell body and
varicosities (see arrowheads). Some small glial cells stained with ApGT1 are found attached
to the cell body and processes (see arrows). b1. Image of three sensory neurons in culture
taken at higher magnification. One confocal section through the middle of the cells showing
ApGT1 immunostaining in the periphery of sensory neuron cell bodies. ApGT1
immunostaining was punctate and was associated with the cytoplasm but not the nucleus of
sensory neurons. b2. Maximal projection image of ApGT1 immunostaining in same sensory
neurons. c. Maximal projection image of a sensory cell showing no staining after peptide
competition with the anti-ApGT1 antibody.
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Fig. 3. ApGT1 is synthesized by sensory neurons
a. Example of an autoradiograph and Western blot of an IP from isolated pleural ganglia and
isolated pedal ganglia incubated for 12 h in label (left side). Note that protein bands at the
top of the western blots appear to correspond to ApGT1 multimers. Ab indicates the band
corresponding to the antibody used in the IP that is detected by the secondary antibody in
Western blots. Summary data (n = 7, right side). The values of labeled ApGT1 were
normalized to total ApGT1 and were made relative to the lowest values (values of Isolated
Pedal). ApGT1 was synthesized at higher rates in pleural than in pedal ganglia. b. An
example of an autoradiograph and Western blot of an IP for SN clusters and the Re Pleural
ganglia incubated for 12 h in label (left side). Note that about the same amount of labeled
ApGT1 is observed in SN clusters and Re pleural but much more ApGT1 is found in Re
Pleural because the amount of total protein obtained is greater than in SN clusters.
Quantification of the results of the experiment in b (right side). ApGT1 was synthesized at
higher rates in SN clusters than in the remainder of pleural ganglia.
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Fig. 4. ApGT1 is transported from pleural ganglia to pedal synaptosomes by fast axoplasmic
transport
Pleural-pedal ganglia were incubated in label for 12 h, then protein synthesis was inhibited
by addition of anisomycin (20 μM) and ganglia were left in culture for different chase
periods of 0 h, 6 h and 12 h (attached pleural-pedal ganglia). Synaptosomes were then
prepared from pedal ganglia and proteins were immunoprecipitated with ApGT1 antibody.
a. Diagram of the experimental protocol and a representative example of an autoradiograph
and Western blot. ACOP (ApGT1 co-precipitating protein) refers to a band running lower
than ApGT1. Protein bands at the top of the western blots appear to correspond to ApGT1
multimers. b. Summary of quantification of all experiments (0h: n = 10, 6h: n = 5, 12h: n =
8). Values were relative to 0 h (basal value when the chase period began, indicated by the
dashed line). Labeled ApGT1 was observed in synaptosomes by 12 h of labeling and 0 h of
chasing and levels increased in a protein synthesis-independent manner after chasing for 6
and 12 h, suggesting that ApGT1 was transported to terminals. c. Colchicine (10 mM) was
added to one group during the 12 h chase period. Also, pleural ganglia were removed from
the pedal ganglia in one group after 12 h of labeling and the isolated pedal ganglia were then
chased for 12 h. Values were relative to 0 h (dashed line). Addition of colchicine completely
abolished the increase of labeled ApGT1 after chasing for 12 h, suggesting that ApGT1 was
transported to the terminals via microtubule-dependent axonal transport. Removal of pleural
ganglia significantly reduced the transported ApGT1 by about 170%. Thus, pleural ganglia
(presumably sensory neuron cell bodies) appear to be a major source of synaptosomal
ApGT1 in pedal ganglia.
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Fig. 5. Synthesis of ApGT1 protein was not regulated by 5-HT
a. Diagram of the experimental protocol. Pleural-pedal ganglia were removed, starved for
methionine and cysteine for 3 h and then incubated in label overall for 8 h. In experimental
groups, 5-HT (50 μM) was added for 2 h. After labeling, ganglia were incubated in culture
media for 12-15 h to allow trafficking of newly synthesized ApGT1 to the terminals. b.
Results from one experiment. IP was started with the same amount of protein in all groups
(15 - 25 μg). c. Summary of quantification. The level of labeled ApGT1 in synaptosomes
was not affected by 5-HT. However, in aliquots taken from the same samples, total
synaptosomal ApGT1 before and after IP was significantly increased by 5-HT (n = 4).
Therefore, the 5-HT induced increase in ApGT1 in pedal synaptosomes does not appear to
be due to an increase in synthesis of ApGT1. d. To investigate whether 5-HT induced
changes in pleural ganglia, levels of newly synthesized ApGT1 were measured in IP’s from
pleural membranes 20 h after treatment of pleural- pedal ganglia with 5-HT. An example of
a 35S autorad of an IP sample and a summary of quantification of experiments are shown.
Newly synthesized ApGT1 was significantly decreased in pleural ganglia 20 h after 5-HT.
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Fig. 6. Somata of sensory neurons are required for the transcription dependent increase in
glutamate uptake by 5-HT
a. (Left) Glutamate uptake was increased significantly by 27 % in pedal synaptosomes
prepared 24h after isolated pedal ganglia were treated with 5-HT (50 μM/1.5 h). DRB, an
inhibitor of transcription, added 30 minutes before 5-HT to the end of the experiment did not
block the long-term increase in glutamate uptake produced by 5-HT (n = 9). DRB alone had
no significant effect on basal glutamate uptake (n = 7). ANOVA followed by Newman
Keul’s post hoc test (F(2,28) = 4.3, 5-HT vs 5-HT + DRB, p > 0.05; 5-HT vs DRB, p < 0.01;
DRB vs 5-HT + DRB, p < 0.05). Asterisk (*) indicates significant % change (p < 0.05) from
the control. (Right) Attached pleural-pedal ganglia were treated with 5-HT (50 μM) for 1.5
h. Pedal ganglia were separated from pleural ganglia 24 h after treatment and glutamate
uptake was measured in synaptosomes derived from pedal ganglia. 5-HT significantly
increased glutamate uptake by 45 % (n = 6, t = 5.7, p < 0.01, paired t-test). b. 5-HT did not
produce long-term increases in glutamate uptake in cultures of isolated processes of sensory
neurons. Sensory neuron cell bodies were excised and sensory neuron processes were treated
with 5-HT (50 μM) for 1.5 h. Glutamate uptake measured 24 h after treatment of sensory
neuron processes with 5-HT did not change. In contrast, cultures of intact isolated sensory
neurons treated with 50 μM for 1.5 h produced significant long-term increases in glutamate
uptake.
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Fig. 7. RER-Golgi-TGN transport is required for the long-term increase in ApGT1 by 5-HT
Isolated pleural-pedal ganglia were treated in vitro with 5-HT and an inhibitor of vesicular
transport Brefeldin A (18 μM) was applied immediately after the 5-HT treatment. Levels of
ApGT1 were measured 24 h after treatments by western blotting. Brefeldin A alone did not
have an effect on levels of ApGT1 (n = 7). ApGT1 was increased when ganglia were treated
with 5-HT (n = 4). Brefeldin A added after 5-HT treatment (n = 5) blocked the increase in
ApGT1 by 5-HT.
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Fig. 8. 5-HT induced changes in post-translational modifications of ApGT1
Isolated pleural-pedal ganglia were treated with 5-HT for 2 h and 24 h later pleural-pedal
membranes were prepared, run in a 2D gel, transferred to PVDF and subsequently blotted
for ApGT1. a. Western blots with spots of proteins corresponding to ApGT1 are shown in
control samples and 5-HT treated samples. Extensive heterogeneity of charge is observed for
ApGT1 as well as a small heterogeneity of molecular weight. Comparison of ApGT1 from
control and 5-HT samples revealed that some spots of ApGT1 found in the control
disappeared or decreased after 5-HT treatment (red boxes; spots # 8, 9, 10, 11) and some
new spots of ApGT1 appeared or increased after 5-HT treatment (yellow boxes; spots # 1, 2,
3, 4, 5, 6, 7). b. Quantification of experiment in a. Overall, it appears that a shift of the
isoforms for ApGT1 towards acidic pH occurred suggesting that 5-HT produced a change in
post-translational modifications of ApGT1.
Collado et al. Page 23
J Neurochem. Author manuscript; available in PMC 2009 May 20.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
